2 months ago
IOVA
AnalystsReni BenjaminReni Benjamin's Stock Forecasts
AnalystsReni Benjamin
Sectors:
Analyst Ranking
Top 10%
#443 out of 4563 analysts
Average Return
+8.26%
Win Rate
50%61 out of 122
Risk vs Reward
Poor
Good
Reni Benjamin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ambrx Biopharma IncAMAM | +188.96% | $9.69 | $28.00 | 2023-11-19 - 2024-03-06 | Buy |
Sana Biotechnology IncSANA | +168.13% | $3.20 | $8.58 | 2023-10-11 - 2024-04-24 | Buy |
Ambrx Biopharma IncAMAM | +160.71% | $10.74 | $28.00 | 2023-09-24 - 2024-03-06 | Buy |
Spark Therapeutics IncONCE | +145.65% | $45.41 | $111.55 | 2018-11-06 - 2019-11-07 | Strong Buy |
Ambrx Biopharma IncAMAM | +138.91% | $11.72 | $28.00 | 2023-11-28 - 2024-03-06 | Buy |
Reni Benjamin Analyst Color
Get additional color on Reni Benjamin's coverage of popular stocks
Reni Benjamin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Blueprint Medicines CorpBPMC | 8 | Buy | $114.00 | +23.56% | Reiterates | 15 days ago |
Sutro Biopharma IncSTRO | 7 | Buy | $17.00 | +389.91% | Reiterates | 22 days ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $12.00 | +87.79% | Initiates Coverage On | 22 days ago |
Bioatla IncBCAB | 6 | Buy | $12.00 | +410.64% | Reiterates | a month ago |
Prelude Therapeutics IncPRLD | 1 | Buy | $7.00 | +80.88% | Initiates Coverage On | a month ago |
Sana Biotechnology IncSANA | 3 | Buy | $15.00 | +74.83% | Maintains | 2 months ago |
Iovance Biotherapeutics IncIOVA | 8 | Buy | $25.00 | +113.49% | Maintains | 2 months ago |
Kura Oncology IncKURA | 3 | Buy | $32.00 | +70.67% | Maintains | 3 months ago |
Bicycle Therapeutics PLCBCYC | 10 | Buy | $32.00 | +41.16% | Maintains | 4 months ago |
Incyte CorpINCY | 13 | Buy | $93.00 | +79.74% | Reiterates | 4 months ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $15.00 | -46.43% | Reiterates | 5 months ago |
Inhibrx IncINBX | 5 | Buy | $27.00 | -21.47% | Reiterates | 5 months ago |
Lava Therapeutics NvLVTX | 4 | Buy | $6.00 | +118.98% | Reiterates | 8 months ago |
Deciphera Pharmaceuticals IncDCPH | 5 | Buy | $23.00 | +57.32% | Reiterates | a year ago |
Allogene Therapeutics IncALLO | 5 | Buy | $15.00 | +393.42% | Reiterates | a year ago |
Cue Biopharma IncCUE | 2 | Buy | $15.00 | +956.34% | Reiterates | a year ago |
Adicet Bio IncACET | 2 | Buy | $19.00 | +913.33% | Reiterates | a year ago |
Cti Biopharma CorpCTIC | 4 | Buy | $9.00 | N/A | Reiterates | a year ago |
Seagen IncSGEN | 5 | Buy | $168.00 | N/A | Maintains | a year ago |
Spectrum Pharmaceuticals IncSPPI | 3 | Buy | $4.00 | N/A | Reiterates | a year ago |
Effector Therapeutics IncEFTR | 5 | Buy | $25.00 | N/A | Maintains | a year ago |
Compugen LtdCGEN | 1 | Buy | $4.00 | N/A | Maintains | 2 years ago |
Trillium Therapeutics IncTRIL | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aceragen IncACGN | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $36.00 | N/A | Initiates Coverage On | 4 years ago |
Eterna Therapeutics IncERNA | 2 | Buy | $5.00 | N/A | Maintains | 5 years ago |
Macrogenics IncMGNX | 2 | Hold | N/A | N/A | Upgrades | 5 years ago |
Regenxbio IncRGNX | 2 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Leap Therapeutics IncLPTX | 2 | Buy | $80.00 | N/A | Maintains | 5 years ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Spark Therapeutics IncONCE | 1 | Strong Buy | $72.00 | N/A | Upgrades | 5 years ago |
Adverum Biotechnologies IncADVM | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Buy | $16.00 | N/A | Maintains | 6 years ago |
Adma Biologics IncADMA | 2 | Buy | $10.00 | N/A | Maintains | 6 years ago |
Tg Therapeutics IncTGTX | 1 | Buy | $12.00 | N/A | Downgrades | 6 years ago |
Urogen Pharma LtdURGN | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Hold | N/A | N/A | Initiates Coverage On | 7 years ago |
Juno Therapeutics IncJUNO | 2 | Buy | N/A | N/A | Upgrades | 7 years ago |
Bellicum Pharmaceuticals IncBLCM | 2 | Buy | $180.00 | N/A | Maintains | 7 years ago |
Organovo Holdings IncONVO | 1 | Buy | $100.00 | N/A | Initiates Coverage On | 7 years ago |
Invivo Therapeutics Holdings CorpNVIVQ | 1 | Strong Buy | $243,750.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.